31P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth

Benjamin Moreno, Brian N. Bailey, Shuhong Luo, Michael B. Martin, Mark Kuhlenschmidt, Silvia N.J. Moreno, Roberto Docampo, Eric Oldfield

Research output: Contribution to journalArticle

Abstract

High-resolution 303.6 MHz 31P NMR spectra have been obtained of perchloric acid extracts of Plasmodium berghei trophozoites, Toxoplasma gondii tachyzoites, and Cryptosporidium parvum oocysts. Essentially complete resonance assignments have been made based on chemical shifts and by coaddition of authentic reference compounds. Signals corresponding to inorganic pyrophosphate were detected in all three species. In T. gondii and C. parvum, additional resonances were observed corresponding to linear triphosphate as well as longer chain polyphosphates. Spectra of P. berghei and T. gondii also indicated the presence of phosphomonoesters and nucleotide phosphates. We also report that the pyrophosphate analog drug, risedronate (used in bone resorption therapy), inhibits the growth of C. parvum in a mouse xenograft model. When taken together, our results indicate that all the major disease-causing apicomplexan parasites contain extensive stores of condensed phosphates and that as with Plasmodium falciparum and T. gondii, the pyrophosphate analog drug risedronate is an inhibitor of C. parvum cell growth.

Original languageEnglish (US)
Pages (from-to)632-637
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume284
Issue number3
DOIs
StatePublished - Jan 1 2001

Keywords

  • Apicomplexan
  • Bisphosphonate
  • Cryptosporidiosis
  • Malaria
  • NMR
  • Toxoplasmosis
  • Xenograft

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of '<sup>31</sup>P NMR of apicomplexans and the effects of risedronate on Cryptosporidium parvum growth'. Together they form a unique fingerprint.

  • Cite this